TSS
RXRX icon

Two Sigma Securities’s Recursion Pharmaceuticals RXRX Stock Holding History

Two Sigma Securities’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Buy
+42,762
New +$142K 0.01% 1218
2026
Q1 		– Sell
-48,970
Closed -$200K – 2130
2025
Q4 		$200K Buy
48,970
+10,007
+26% +$49.6K 0.03% 872
2025
Q3 		$190K Sell
38,963
-3,494
-8% -$18.3K 0.03% 825
2025
Q2 		$215K Buy
42,457
+15,493
+57% +$76.1K 0.03% 880
2025
Q1 		$143K Buy
+26,964
New +$197K 0.02% 895

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Securities's RXRX Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Recursion Pharmaceuticals (RXRX) in Q2 2026: 42,762 shares worth $157K. The stake represents 0.01% of the portfolio and ranks #1218 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in RXRX as recently as Q4 2025.

Two Sigma Securities first reported a position in RXRX in Q1 2025 and has held it in 5 quarters since. The position peaked at $215K in Q2 2025. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Two Sigma Securities held 42,762 shares of Recursion Pharmaceuticals worth $157K as of Q2 2026.
  • Recursion Pharmaceuticals was a new Two Sigma Securities position in Q2 2026.
  • Recursion Pharmaceuticals made up 0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1218 holding.
  • Two Sigma Securities first reported a position in Recursion Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Two Sigma Securities's Recursion Pharmaceuticals position peaked at $215K in Q2 2025.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.